Case Report: Primary Hypothyroidism Associated With Lutetium 177-DOTATATE Therapy for Metastatic Paraganglioma

BACKGROUND: Lutetium 177 ((177)Lu) - DOTATATE is a form of peptide receptor radionuclide therapy (PRRT) utilized in the treatment of neuroendocrine tumors. Data on (177)Lu-DOTATATE-induced thyroid dysfunction is limited. CASE DESCRIPTION: A 29-year-old male with SDHB positive metastatic paragangliom...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Front Endocrinol (Lausanne)
Glavni autori: Gubbi, Sriram, Al-Jundi, Mohammad, Del Rivero, Jaydira, Jha, Abhishek, Knue, Marianne, Zou, Joy, Turkbey, Baris, Carrasquillo, Jorge Amilcar, Lin, Emily, Pacak, Karel, Klubo-Gwiezdzinska, Joanna, Lin, Frank I-Kai
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2021
Teme:
Endocrinology
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7859638/
https://ncbi.nlm.nih.gov/pubmed/33551992
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2020.587065
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items